Status: Recruiting
The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children
This study is a multicenter, randomized controlled crossover trial aimed to evaluate the efficacy and safety of dapagliflozin in the treatment of hereditary kidney disease with proteinuria in children
Participants needed: 44
Trial details
Phase: Phase 3Age: 6-18Biological sex: AllType: InterventionalSponsor: Children's Hospital of Fudan UniversityUpdated: Jul 6, 2026Locations: 1
Eligibility criteria
Confirmed diagnosis of hereditary kidney disease (identification of pathogenic g... [+4]
Treatment with hormones/immunosuppressive agents within the previous 4 weeks. [+14]